Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aurinia Pharmaceuticals Inc. | Chief Commercial Officer | Common Stock | 456K | $2.42M | $5.31 | Aug 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AUPH | Aurinia Pharmaceuticals Inc. | Aug 6, 2024 | 1 | -$96.9K | 4 | Aug 8, 2024 | Chief Commercial Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Mar 6, 2024 | 1 | -$99.6K | 4 | Mar 7, 2024 | Chief Commercial Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Feb 20, 2024 | 2 | -$87K | 4 | Feb 22, 2024 | Chief Commercial Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Mar 2, 2023 | 1 | $0 | 4 | Mar 6, 2023 | Chief Commercial Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Nov 9, 2022 | 1 | $25.1K | 4 | Nov 14, 2022 | Chief Commercial Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Aug 1, 2022 | 2 | $0 | 4 | Aug 1, 2022 | Chief Commercial Officer |
AUPH | Aurinia Pharmaceuticals Inc. | Jul 18, 2022 | 0 | $0 | 3 | Jul 19, 2022 | Chief Commercial Officer |